How does ivermectin overdose physiologically affect the nervous system and organs?
This fact-check may be outdated. Consider refreshing it to get the most current information.
Executive summary
Ivermectin overdoses primarily cause central nervous system (CNS) depression — from dizziness, ataxia and drowsiness to seizures, coma and death — with gastrointestinal, ocular and dermatologic effects commonly reported; case series show neurotoxicity as the most frequent organ-system involvement (CNS 40%, GI 27.7%) [1][2]. Severe neurotoxicity is linked to high doses, veterinary-product exposures, co‑administered CNS depressants, blood–brain‑barrier compromise, or loss of the ABCB1/P‑glycoprotein brain efflux function [3][4][5].
1. How ivermectin acts at the molecular level — why parasites and not people (usually)
Ivermectin binds glutamate‑gated chloride channels in parasites, opening chloride channels and causing paralysis and death; mammalian neurons normally lack those parasite channels and express other ligand‑gated chloride channels that are protected from ivermectin by the ABCB1 (P‑glycoprotein/ABCB1) efflux transporter at the blood–brain barrier, so usual therapeutic doses produce minimal CNS exposure [6][5].
2. When protection fails — routes to brain exposure and neurotoxicity
Overdose, ingestion of highly concentrated veterinary formulations, co‑ingested CNS depressants, skin lesions enhancing dermal absorption, or genetic loss‑of‑function in ABCB1 let ivermectin accumulate in the CNS. Case reports and series implicate accidental veterinary product use, very large doses, or ABCB1 nonsense mutations that abolish efflux and permit brain accumulation and severe neurologic effects [2][7][4].
3. The clinical toxidrome — what the nervous system and organs do under overdose
Neurological signs dominate: dizziness, drowsiness, ataxia, tremor, depressed consciousness, confusion, hallucinations, seizure activity, coma and respiratory depression in severe cases; ocular effects (including transient visual disturbance or blindness), gastrointestinal symptoms (nausea, vomiting, diarrhea, abdominal pain), hypotension and dermatologic reactions are also reported [7][1][8][9]. In pooled reports the CNS was affected in about 40% of poisoning cases, with GI next most common (27.7%) [1].
4. Mechanistic hypotheses behind neurological damage
The simplest mechanism is excessive agonism or allosteric modulation of inhibitory channels in human CNS — ivermectin can modulate GABA A and other ligand‑gated chloride channels at high concentrations, enhancing inhibitory neurotransmission and producing CNS depression; animal and in‑vitro work, and human case studies, support direct CNS effects once brain exposure rises [4][10]. Case reports also point to polyneuropathy and encephalopathy after exposure, suggesting both central and peripheral nervous system involvement [11].
5. Who is at special risk — hidden vulnerabilities
People who ingest veterinary products (often much higher concentration), the elderly taking high or repeated doses, those on benzodiazepines/barbiturates or other CNS depressants, and individuals with ABCB1 variants that impair brain efflux are at markedly increased risk of severe toxicity and respiratory failure [2][8][4]. Published advisories explicitly warn that ivermectin can potentiate other CNS depressants, raising overdose risk [8].
6. Outcomes and treatment — supportive care and limits of evidence
There is no specific antidote; management is supportive and may include airway/respiratory support, seizure control and activated charcoal if early and ingestion substantial — case reports describe recovery after supportive measures but also deaths in severe exposures [5][8][12]. Experimental approaches (e.g., flumazenil, vitamin C) show benefit in animal models but lack established human‑treatment guidelines and require further study [10].
7. Broader context and competing interpretations
Multiple public‑health notices and case series tie post‑COVID‑19 self‑use and veterinary product misuse to a rise in poison‑center calls and hospitalizations, emphasizing real‑world overdoses [8][2]. Some literature frames ivermectin as “generally safe” at therapeutic doses and stresses ABCB1‑dependent protection [5][6]; opposing reports document serious neurologic adverse events in community treatment campaigns and accidental overdoses, attributing harm to high exposure, coinfections (Loa loa) or genetic/physiologic breaches of the blood–brain barrier [3][11].
8. What the sources do not settle
Available sources do not mention a universally effective antidote approved for humans. They also do not provide a single, evidence‑based human protocol with randomized‑trial data for treating ivermectin overdose; most guidance is case‑based and supportive [5][10]. Exact dose thresholds for irreversible damage in humans remain imprecise in current reporting [7][1].
Bottom line: Ivermectin overdose primarily injures the nervous system by permitting the drug to reach and overstimulate inhibitory channels in the brain and peripheral nervous system; the ABCB1 efflux pump normally prevents this, but high doses, veterinary formulations, drug interactions, skin absorption, or ABCB1 mutations remove that protection and lead to CNS depression, seizures, coma and organ compromise — management is supportive and guided by case reports and toxicology advisories [5][8][1].